There is a growing relationship between BASHH and IUSTI.1 In 2023, several BASHH scholars were invited to give feedback on the IUSTI conference in Malta.

Despite good evidence for HIV and syphilis screening in asymptomatic patients, evidence is lacking for other STIs, for example, Neisseria gonorrhoeae and Chlamydia trachomatis. Kenyon et al 2 highlighted the potential harms of widespread screening for asymptomatic STIs, particularly in HIV-pre-exposure prophylaxis (HIV-PrEP) cohorts, namely increased antimicrobial consumption and antimicrobial resistance (AMR). In Belgium, clinics have reduced asymptomatic STI screening in men who have sex with men using HIV-PrEP: what we need now are patient perspectives and involvement if we are to reduce screening in an attempt to curtail AMR.

STIs in teenagers & adolescents: Errol Fields, (USA)

Fields et al 3 presented interventions developed in Baltimore, USA, to …